TAAIS Annual Meeting Evaluation

Now that you have completed this activity, please provide feedback regarding its quality and the impact it will have on your practice.

*
12345
Learning Objective 1: Describe the presentation and diagnostic criteria for Mastocytosis and mast cell activation syndromes.
Learning Objective 2: Explain how to diagnose and manage delayed hypersensitivity reactions.
Learning Objective 3: Outline Texas Newborn Screen (NBS) for SCID (TRECs) outcomes since 2012 and review the immune approach for infants with abnormal TREC results from NBS.
Learning Objective 4: Recognize some of the pitfalls of ICD10 for allergy practice and describe how to deal with them.
Learning Objective 5: Recognize some of the pitfalls of ICD10 for allergy practice and describe how to deal with them.
Learning Objective 6: Describe the risk factors and new prevention strategies for peanut allergy.
Learning Objective 7: Discuss the tools to provide improved food allergy education.
Learning Objective 8: Explain the use of biologics in refractory chronic rhinosinusitis.
Learning Obejctive 9: Demonstrate competence in allergen selection and administration in successful immunotherapy regimens.
Learning Objective 10: Identify patient indications, immunologic mechanisms, and special considerations related to immunotherapy delivery.
Learning Objective 11: Recognize contemporary issues relevant to allergic contact dermatitis.
Learning Objective 12: Develop a differential diagnosis, diagnostic testing strategy and management plan when presented with challenging Allergy & Immunology cases.
*
PoorFairGoodVery GoodExcellent
Quality of the content
Quality of the format
Relevance to your practice (patient care, research, teaching)
*
*